{ "items": [ "\n\n
\n \n 15 December 2021\n \n
\n\n \n \n \n\n \n \n \nScientists at the Oxford Parkinson's Disease Centre (OPDC) have been able to use a highly-sensitive method called \u03b1-synuclein real-time quaking-induced conversion (\u03b1Syn-RT-QuIC) to observe the clumping of alpha-synuclein in the cerebrospinal fluid (CSF) taken from people with Parkinson\u2019s. The findings offer hope that a pioneering new clinical test could be developed to diagnose Parkinson\u2019s correctly in its early stages.
\n \n\n\n \n 15 December 2021\n \n
\n\n \n \n \n\n \n \n \nResearchers used blood samples collected from Com-COV2 study participants who had received two doses of standard COVID-19 vaccination schedules to perform neutralisation assays using Omicron virus isolate.\r\n\r\nSubstantial fall in neutralising titres suggest that while there is no evidence of increased potential to cause severe disease, or death, increased infections in previously infected, or vaccinated individuals may be likely.\r\n\r\nIncreasing vaccine uptake among unvaccinated, and encouraging third doses, remain priority to reduce \r\ntransmission levels and potential for severe disease.
\n \n\n\n \n 15 December 2021\n \n
\n\n \n \n \n\n \n \n \nThe world\u2019s largest clinical trial investigating treatments for COVID-19 has now launched in South Africa, with the first patient recruited today. This is the fifth country to take part in RECOVERY, joining Nepal, Indonesia, Vietnam, and the United Kingdom.
\n \n\n\n \n 9 December 2021\n \n
\n\n \n \n \n\n \n \n \nEstimates of COVID-19 vaccine uptake in the USA based on large surveys that are used to guide policy-making decisions tend to overestimate the number of vaccinated individuals, research published in Nature suggests.
\n \n\n\n \n 9 December 2021\n \n
\n\n \n \n \n\n \n \n \nBy Professors Xiaolan Fu and Diego S\u00e1nchez-Ancochea of the Oxford Department of International Development
\n \n\n\n \n 9 December 2021\n \n
\n\n \n \n \n\n \n \n \nProfessor Dame Sarah Gilbert, Sa\u00efd Professorship of Vaccinology, Jenner Institute & Nuffield Department of Clinical Medicine, delivered the 44th Richard Dimbleby Lecture, named after the late broadcaster, Richard Dimbleby.
\n \n\n\n \n 9 December 2021\n \n
\n\n \n \n \n\n \n \n \nFollowing up first doses of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines with second doses of the Moderna or Novavax jabs will generate robust immune responses against COVID-19, according to researchers running the University of Oxford-led Com-COV study.
\n \n\n\n \n 30 November 2021\n \n
\n\n \n \n \n\n \n \n \nHer Majesty The Queen has approved the award of The Queen\u2019s Anniversary Prizes to twenty-one higher and further education institutions, including Oxford University, in the most recent round of the independently reviewed scheme. This prestigious award is the highest national honour available to universities and FE colleges across the UK.
\n \n\n\n \n 30 November 2021\n \n
\n\n \n \n \n\n \n \n \nThe team at the University of Oxford\u2019s Jenner Institute has been celebrated for their global pandemic work by The Oxford Trust\u2019s Covid Innovation Heroes Award\u00ad 2021.
\n \n\n\n \n 29 October 2021\n \n
\n\n \n \n \n\n \n \n \nUsing cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments.
\n \n\n\n \n 29 October 2021\n \n
\n\n \n \n \n\n \n \n \nA major new $9 million (\u00a36.6 million) University of Oxford-led project funded by the Aligning Science Across Parkinson\u2019s (ASAP) initiative will map the original brain circuits vulnerable to Parkinson\u2019s on an unprecedented scale. It is the only UK-led ASAP project this year, and the first ever to be led by Oxford.
\n \n\n\n \n 29 October 2021\n \n
\n\n \n \n \n\n \n \n \nPeople who wore face coverings or masks outside of the home, and were more exposed to infection due to their circumstances, had \u2018significantly\u2019 lower rates of COVID-19 infection, according to research published in BMJ Open today, led by Oxford\u2019s Leverhulme Centre for Demographic Science.
\n \n\n\n \n 29 October 2021\n \n
\n\n \n \n \n\n \n \n \nHopes that tamoxifen could improve survival for a deadly form of fungal meningitis have been dashed by the results of a clinical trial conducted by University of Oxford researchers and published today in eLife.
\n \n\n\n \n 11 October 2021\n \n
\n\n \n \n \n\n \n \n \nA new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.
\n \n\n\n \n 11 October 2021\n \n
\n\n \n \n \n\n \n \n \nResearchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.
\n \n\n\n \n 21 September 2021\n \n
\n\n \n \n \n\n \n \n \n\u2018Finding Our Way \u2013 An NHS Tribute Garden\u2019 is a celebration of the incredible efforts of the thousands of people who fought \u2013 and are still fighting - the COVID-19 pandemic on our behalf. The garden is designed by Naomi Ferrett-Cohen and presented by Oxford University Hospitals NHS Foundation Trust and Oxford University.
\n \n\n\n \n 4 August 2021\n \n
\n\n \n \n \n\n \n \n \nWhy we sleep, and the processes behind sleep, are amongst the most interesting questions in modern neuroscience.
\n \n\n\n \n 4 August 2021\n \n
\n\n \n \n \n\n \n \n \nTrial aims to evaluate safety, tolerability, and immunogenicity of vaccine candidate\r\nFirst dose given today, in Lusaka, Zambia\r\nVaccine aims to combat numerous HIV strains, a key requirement of any vaccine to end the HIV/AIDs epidemic\r\nThe Globally Relevant AIDS Vaccine Europe-Africa Trials Partnership (GREAT) \u2013 of which the University of Oxford is a lead partner \u2013 announced today the start of vaccinations in a Phase I clinical trial of a novel HIV vaccine candidate.
\n \n\n\n \n 4 August 2021\n \n
\n\n \n \n \n\n \n \n \nThe Chief Midwifery Officer for England will urge expectant mums to have their COVID-19 vaccination as soon as possible. This follows a worrying rise in unvaccinated women being admitted to hospital with severe COVID-19, and evidence that the Delta variant poses a significantly greater risk than all previous strains.
\n \n\n\n \n 4 August 2021\n \n
\n\n \n \n \n\n \n \n \nA study involving nearly half a million people in China reveals a clear link between cooking with wood or coal, and an increased risk of major eye diseases that can lead to blindness, according to a report published today in PLOS Medicine.
\n \n\n